Back
Ultragenyx Pharmaceutical Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
2
RARE
Ultragenyx Pharmaceutical
Last Price:
$27.64
Seasonality Move:
-4.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.09 | Sell |
| 20-day SMA: | 35.65 | Sell |
| 50-day SMA: | 35.92 | Sell |
| 200-day SMA: | 42.44 | Sell |
| 8-day EMA: | 24.87 | Buy |
| 20-day EMA: | 15.74 | Buy |
| 50-day EMA: | 7.76 | Buy |
| 200-day EMA: | 2.17 | Buy |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.05 | Buy |
| Relative Strength Index (14 RSI): | 27.59 | Sell |
| Chaikin Money Flow: | -1696611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.2 - 39.94) | Sell |
| Bollinger Bands (100): | (33.84 - 40.14) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 27.31 while RARE 8-day simple moving average is 33.09, which is a Sell signal.
-
The stock price of RARE is 27.31 while Ultragenyx Pharmaceutical 20-day SMA is 35.65, which makes it a Sell.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 35.92 while RARE share price is 27.31, making it a Sell technically.
-
RARE stock price is 27.31 and Ultragenyx Pharmaceutical 200-day simple moving average is 42.44, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
2
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $27.31. The Score for RARE is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
2.6B
Price in USD:
27.31
Share Volume:
3M
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
26.85
Sell
2
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 27.31 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 27.31 while RARE 8-day exponential moving average is 24.87, which is a Buy signal.
-
The stock price of RARE is 27.31 while Ultragenyx Pharmaceutical 20-day EMA is 15.74, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 7.76 while RARE share price is 27.31, making it a Buy technically.
-
RARE stock price is 27.31 and Ultragenyx Pharmaceutical 200-day simple moving average is 2.17, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.34 per share, an increase this year of $0.83 per share, and an increase next year of $2.00 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is 8.05, suggesting Ultragenyx Pharmaceutical is a Buy
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 27.59, which suggest Ultragenyx Pharmaceutical is oversold
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (32.2 - 39.94), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (33.84 - 40.14), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.